Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Charles Chen
Medigen Vaccine Biologics Corp.
Taiwan
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
456
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted With CpG 1018 and Aluminum Hydroxide in Healthy Adults: A Phase 1, Dose-Escalation Study
Number of pages: 22
Posted: 15 Apr 2021
Szu-Min Hsieh
,
Wang-Da Liu
,
Yu-Shan Huang
,
Yi‑Jiun Lin
,
Erh-Fang Hsieh
,
Wei-Cheng Lian
, Charles Chen,
Robert Janssen
,
I-Chen Tai
and
Shan-Chwen Chang
National Taiwan University - Section of Infectious Diseases, National Taiwan University - Section of Infectious Diseases, National Taiwan University - Section of Infectious Diseases, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Dynavax Technologies Corporation, Medigen Vaccine Biologics Corp. and National Taiwan University - Section of Infectious Diseases
Downloads
456
(157,424)
Citation
1
View PDF
Download
Abstract:
COVID-19 vaccine; CpG 1018; S-2P protein
Feedback
